Literature DB >> 20543078

Mitochondrial dysfunction in the type 2 diabetic heart is associated with alterations in spatially distinct mitochondrial proteomes.

Erinne R Dabkowski1, Walter A Baseler, Courtney L Williamson, Matthew Powell, Trust T Razunguzwa, Jefferson C Frisbee, John M Hollander.   

Abstract

Cardiac complications and heart failure are the leading cause of death in type 2 diabetic patients. Mitochondrial dysfunction is central in the pathogenesis of the type 2 diabetic heart. However, it is unclear whether this dysfunction is specific for a particular subcellular region. The purpose of this study was to determine whether mitochondrial dysfunction in the type 2 diabetic heart is specific to a spatially distinct subset of mitochondria. We investigated mitochondrial morphology, function, and proteomic composition of subsarcolemmal mitochondria (SSM) and interfibrillar mitochondria (IFM) in 18-wk-old db/db mice. Oxidative damage was assessed in subpopulations through the measurement of lipid peroxidation byproducts and nitrotyrosine residues. Proteomic profiles and posttranslational modifications were assessed in mitochondrial subpopulations using iTRAQ and multi-dimensional protein identification technologies, respectively. SSM from db/db hearts had altered morphology, including a decrease in size and internal complexity, whereas db/db IFM were increased in internal complexity. Db/db SSM displayed decreased state 3 respiration rates, electron transport chain activities, ATP synthase activities, and mitochondrial membrane potential and increased oxidative damage, with no change in IFM. Proteomic assessment revealed a greater impact on db/db SSM compared with db/db IFM. Inner mitochondrial membrane proteins, including electron transport chain, ATP synthesis, and mitochondrial protein import machinery, were predominantly decreased. We provide evidence that mitochondrial dysfunction in the type 2 diabetic heart is associated with a specific subcellular locale. Furthermore, mitochondrial morphological and functional indexes are impacted differently during type 2 diabetic insult and may result from the modulation of spatially distinct mitochondrial proteomes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20543078      PMCID: PMC2930393          DOI: 10.1152/ajpheart.00267.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  43 in total

Review 1.  Adaptation and maladaptation of the heart in diabetes: Part I: general concepts.

Authors:  Heinrich Taegtmeyer; Patrick McNulty; Martin E Young
Journal:  Circulation       Date:  2002-04-09       Impact factor: 29.690

2.  Partial resolution of the enzymes catalyzing oxidative phosphorylation. I. Purification and properties of soluble dinitrophenol-stimulated adenosine triphosphatase.

Authors:  M E PULLMAN; H S PENEFSKY; A DATTA; E RACKER
Journal:  J Biol Chem       Date:  1960-11       Impact factor: 5.157

3.  Impaired cardiac functional reserve in type 2 diabetic db/db mice is associated with metabolic, but not structural, remodelling.

Authors:  A Daniels; M van Bilsen; B J A Janssen; A E Brouns; J P M Cleutjens; T H M Roemen; G Schaart; J van der Velden; G J van der Vusse; F A van Nieuwenhoven
Journal:  Acta Physiol (Oxf)       Date:  2010-02-17       Impact factor: 6.311

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  Use of polarography to detect respiration defects in cell cultures.

Authors:  G Hofhaus; R M Shakeley; G Attardi
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

6.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

7.  Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy.

Authors:  Milton Hamblin; David B Friedman; Salisha Hill; Richard M Caprioli; Holly M Smith; Michael F Hill
Journal:  J Mol Cell Cardiol       Date:  2007-01-10       Impact factor: 5.000

Review 8.  Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes.

Authors:  Sihem Boudina; E Dale Abel
Journal:  Physiology (Bethesda)       Date:  2006-08

9.  Mitochondria-specific transgenic overexpression of phospholipid hydroperoxide glutathione peroxidase (GPx4) attenuates ischemia/reperfusion-associated cardiac dysfunction.

Authors:  Erinne R Dabkowski; Courtney L Williamson; John M Hollander
Journal:  Free Radic Biol Med       Date:  2008-06-30       Impact factor: 7.376

Review 10.  Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes.

Authors:  Patrick Schrauwen; Matthijs K C Hesselink
Journal:  Diabetes       Date:  2004-06       Impact factor: 9.461

View more
  77 in total

1.  Cardioproteomics: advancing the discovery of signaling mechanisms involved in cardiovascular diseases.

Authors:  Ziyou Cui; Shannamar Dewey; Aldrin V Gomes
Journal:  Am J Cardiovasc Dis       Date:  2011-09-10

Review 2.  Mitochondria in the pathogenesis of diabetes: a proteomic view.

Authors:  Xiulan Chen; Shasha Wei; Fuquan Yang
Journal:  Protein Cell       Date:  2012-06-22       Impact factor: 14.870

3.  Translational Regulation of the Mitochondrial Genome Following Redistribution of Mitochondrial MicroRNA in the Diabetic Heart.

Authors:  Rajaganapathi Jagannathan; Dharendra Thapa; Cody E Nichols; Danielle L Shepherd; Janelle C Stricker; Tara L Croston; Walter A Baseler; Sara E Lewis; Ivan Martinez; John M Hollander
Journal:  Circ Cardiovasc Genet       Date:  2015-09-16

Review 4.  Mitochondrial health, the epigenome and healthspan.

Authors:  Miguel A Aon; Sonia Cortassa; Magdalena Juhaszova; Steven J Sollott
Journal:  Clin Sci (Lond)       Date:  2016-08-01       Impact factor: 6.124

5.  Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction.

Authors:  Walter A Baseler; Erinne R Dabkowski; Courtney L Williamson; Tara L Croston; Dharendra Thapa; Matthew J Powell; Trust T Razunguzwa; John M Hollander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-03       Impact factor: 3.619

6.  miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart.

Authors:  Walter A Baseler; Dharendra Thapa; Rajaganapathi Jagannathan; Erinne R Dabkowski; Tara L Croston; John M Hollander
Journal:  Am J Physiol Cell Physiol       Date:  2012-10-03       Impact factor: 4.249

7.  Functional deficiencies of subsarcolemmal mitochondria in the type 2 diabetic human heart.

Authors:  Tara L Croston; Dharendra Thapa; Anthony A Holden; Kevin J Tveter; Sara E Lewis; Danielle L Shepherd; Cody E Nichols; Dustin M Long; I Mark Olfert; Rajaganapathi Jagannathan; John M Hollander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-04-28       Impact factor: 4.733

Review 8.  Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.

Authors:  Olesya Ilkun; Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Mitochondrial remodeling in mice with cardiomyocyte-specific lipid overload.

Authors:  Aly Elezaby; Aaron L Sverdlov; Vivian H Tu; Kanupriya Soni; Ivan Luptak; Fuzhong Qin; Marc Liesa; Orian S Shirihai; Jamie Rimer; Jean E Schaffer; Wilson S Colucci; Edward J Miller
Journal:  J Mol Cell Cardiol       Date:  2014-12-09       Impact factor: 5.000

10.  Cardiac and mitochondrial dysfunction following acute pulmonary exposure to mountaintop removal mining particulate matter.

Authors:  Cody E Nichols; Danielle L Shepherd; Travis L Knuckles; Dharendra Thapa; Janelle C Stricker; Phoebe A Stapleton; Valerie C Minarchick; Aaron Erdely; Patti C Zeidler-Erdely; Stephen E Alway; Timothy R Nurkiewicz; John M Hollander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-23       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.